Diagnosis of antiphospholipid syndrome in routine clinical practice

Lupus

Volumn 22, Issue 1, 2013, Pages 18-25

  Gardiner, C ^a,c   Hills, J ^a   MacHin, S J ^a,b   Cohen, H ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DYSTONIA; FEMALE; HUMAN; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; FEMALE; HUMANS; LINEAR MODELS; LUPUS COAGULATION INHIBITOR; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84871552087     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312460722     Document Type: Article

References (38)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Galli M, Reber G, de MP DE, Groot PG. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost. 2008 ; 6: 399-401
3. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003 ; 101: 1827-1832
4. Opatrny L, David M, Kahn SR, Shrier I, Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a meta-analysis. J Rheumatol. 2006 ; 33: 2214-2221
5. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009 ; 7: 1737-1740
6. Nash MJ, Camilleri RS, Kunka S, Mackie IJ, Machin SJ, Cohen H. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost. 2004 ; 2: 1077-1081
7. Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, et al. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. J Thromb Haemost. 2009 ; 102: 25-28
8. Wahl D, Thiebaugeorges O, Regnault V, Dalloul A, Lecompte T. Pursuing the debate on the serologic criteria that define the antiphospholipid syndrome. J Thromb Haemost. 2008 ; 6: 1433-1435
9. Ruffatti A, Olivieri S, Tonello M, Bortolati M, et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost. 2008 ; 6: 1693-1696
10. Cohn DM, Goddijn M, Middeldorp S, Korevaar JC, Dawood F, Farquharson RG. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010 ; 8: 2208-2213
11. Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis. 2003 ; 62: 1127-1127
12. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum. 2007 ; 57: 1487-1495
13. Kasthuri RS, Roubey RA. Warfarin and the antiphospholipid syndrome: does one size fit all?. Arthritis Rheum. 2007 ; 57: 1346-1347
14. McNally T, Purdy G, Mackie IJ, Machin SJ, Isenberg DA. The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol. 1995 ; 91: 471-473
15. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol. 1985 ; 62: 738-745
16. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 ; 68: 215-222
17. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002 ; 100: 408-413
18. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol. 1995 ; 34: 1031-1036
19. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 ; 74: 1185-1190
20. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000 ; 109: 704-715
21. Rooney AM, McNally T, Mackie IJ, Machin SJ. The Taipan snake venom time: a new test for lupus anticoagulant. J Clin Pathol. 1994 ; 47: 497-501
22. Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010 ; 8: 237-242
23. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991 ; 77: 2641-8
24. Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res. 2009 ; 123: 482-487
25. Ruffatti A, Tonello M, Del RT, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. J Thromb Haemost. 2006 ; 96: 337-341
26. Chauleur C, Galanaud JP, Alonso S, et al. Observational study of pregnant women with a previous spontaneous abortion before the 10 gestation week with and without antiphospholipid antibodies. J Thromb Haemost. 2010 ; 8: 699-706
27. Greco TP, Conti-Kelly AM, Matsuura E, et al. Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?. Ann N Y Acad Sci. 2007 ; 1108: 466-474
28. Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009 ; 79: 188-195
29. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995 ; 10: 3301-3304
30. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997 ; 314: 253-257
31. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gyneco. 1996 ; 174: 1584-1589
32. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol. 2002 ; 118: 548-557
33. Pierangeli SS, Harris EN. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is?. Semin Thromb Hemost. 2008 ; 34: 313-328
34. Reber G, Schousboe I, Tincani A, et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. J Thromb Haemost. 2002 ; 88: 66-73
35. Cavazzana A, Pengo V, Tonello M, et al. Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations. J Thromb Haemost. 2009 ; 101: 789-791
36. Brighton TA, Dai YP, Hogg PJ, Chesterman CN. Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids. Biochem J. 1999 ; 340: 59-67
37. Bertolaccini ML, Gomez S, Pareja JF, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005 ; 64: 1639-1643
38. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012 ;: